STOCK TITAN

Calisa Acquisition flags going-concern doubt in Q3

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Calisa Acquisition Corp. (ALIS) reported third-quarter net income of $334,007, versus a $61,783 loss in 2025; nine-month net income was $653,077, versus an $84,486 loss. Trust Account interest was $561,951 for the quarter and $1,632,889 for nine months, while formation and operating costs were $229,798 and $987,178. The company has generated no operating revenue.

At September 30, 2026, cash outside the Trust Account was $195,720, working capital was $77,723, and Trust Account assets were $62,062,113. Management said liquidity, expected expenses and the April 23, 2027 mandatory liquidation date raise substantial doubt about going concern; its plans do not alleviate that doubt. Disclosure controls were ineffective due to a material weakness involving inadequate segregation of duties and insufficient written policies and procedures.

Shareholders approved the proposed Goodvision merger on October 8, 2026, but it remained unclosed pending remaining conditions. The merger agreement sets per-share consideration using 18,000,000 ALIS ordinary shares divided by Goodvision’s fully diluted share count, with up to 3,600,000 conditional earnout shares. The amended forward purchase agreement provides for up to 3,000,000 existing shares and 50,000 Commitment Shares, with prepayment from the trust; subscriptions for 900,000 shares and $9,000,000 also remained contingent on closing.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 2 points

How the balance works

Positive

  • Moderate pointThird-quarter net income was $334,007, versus a $61,783 loss in 2025.
  • Minor pointNine-month net income was $653,077, versus an $84,486 loss in 2025.

Negative

  • Major pointGoing-concern doubt remains ahead of the April 23, 2027 mandatory liquidation date.
  • Major pointA material weakness left disclosure controls ineffective on September 30, 2026.

Filing Explained

The amended forward-purchase agreement was not effective and no prepayment had been funded as of November 13, 2026; if activated, it would draw trust cash for up to 3,000,000 existing shares and 50,000 Commitment Shares, reducing funds available to the combined company. It has a 15-month term after closing, with unsold shares returned at maturity.

Third-quarter net income $334,007 Three months ended September 30, 2026; compared with a $61,783 net loss in 2025.
Nine-month net income $653,077 Nine months ended September 30, 2026; compared with an $84,486 net loss in 2025.
Trust Account assets $62,062,113 As of September 30, 2026.
Cash outside Trust Account $195,720 As of September 30, 2026.
Working capital $77,723 As of September 30, 2026.
Merger consideration formula 18,000,000 ordinary shares Numerator divided by Goodvision’s fully diluted share count to determine per-share merger consideration.
Earnout shares Up to 3,600,000 shares Subject to the agreement’s revenue and share-price conditions.
Forward Purchase Shares Up to 3,000,000 existing ordinary shares Provided for in the amended forward purchase agreement.
Trust Account financial
"Cash and investments held in Trust Account"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
substantial doubt financial
"raise substantial doubt about the Company’s ability to continue as a going concern"
material weakness technical
"not effective due to a material weakness involving inadequate segregation of duties"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
Prepaid Forward Purchase Agreement financial
"entered into a Prepaid Forward Purchase Agreement"
Earnout Shares financial
"Goodvision shareholders will be entitled to receive additional Earnout Shares"
Earnout shares are company stock promised to sellers as part of an acquisition that only becomes payable if the acquired business hits agreed future performance targets, like revenue or profit goals. They matter to investors because they can increase the number of shares outstanding (dilution), tie seller incentives to future success, and create uncertainty about the actual cost of the deal and future ownership unless the performance conditions are clearly understood.
temporary equity financial
"presented as temporary equity outside of shareholders’ equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much net income did ALIS report?

ALIS reported net income of $334,007 for the three months ended September 30, 2026 and $653,077 for the nine months ended September 30, 2026. The comparable 2025 periods had net losses of $61,783 and $84,486, respectively.

Has ALIS completed its Goodvision merger?

No. Shareholders approved the proposed merger on October 8, 2026, but it had not closed as of November 13, 2026. The remaining closing conditions still had to be satisfied or waived.

What conditions apply to ALIS's Goodvision merger earnout shares?

The agreement provides for up to 3,600,000 earnout shares in two 1,800,000-share tranches. The first requires fiscal 2026 net revenue above $19.9 million and a $12.00 share-price threshold; the second requires fiscal 2027 net revenue above $106.0 million and a $15.00 threshold. Each price threshold must be met for 20 trading days within a 30-consecutive-trading-day period under the agreement’s timing terms.

What does ALIS's amended forward purchase agreement provide?

It provides for purchases of up to 3,000,000 Forward Purchase Shares and 50,000 Commitment Shares, with both included in the Trust Account prepayment. It becomes effective one settlement cycle after the pricing date, which follows closing and delivery of the investors’ notice, and has a 15-month maturity period after closing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0002026767 00-0000000 0002026767 2026-01-01 2026-09-30 0002026767 ALIS:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-01-01 2026-09-30 0002026767 ALIS:OrdinarySharesParValue0.000075PerShareMember 2026-01-01 2026-09-30 0002026767 ALIS:RightsEachEntitlingHolderToOnetenthOfOneOrdinaryShareUponCompletionOfCompanysInitialBusinessCombinationMember 2026-01-01 2026-09-30 0002026767 2026-11-13 0002026767 2026-09-30 0002026767 2025-12-31 0002026767 us-gaap:NonrelatedPartyMember 2026-09-30 0002026767 us-gaap:NonrelatedPartyMember 2025-12-31 0002026767 us-gaap:RelatedPartyMember 2026-09-30 0002026767 us-gaap:RelatedPartyMember 2025-12-31 0002026767 2026-07-01 2026-09-30 0002026767 2025-07-01 2025-09-30 0002026767 2025-01-01 2025-09-30 0002026767 ALIS:RedeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002026767 ALIS:RedeemableOrdinarySharesMember 2026-01-01 2026-09-30 0002026767 ALIS:NonRedeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002026767 ALIS:NonRedeemableOrdinarySharesMember 2025-07-01 2025-09-30 0002026767 ALIS:NonRedeemableOrdinarySharesMember 2026-01-01 2026-09-30 0002026767 ALIS:NonRedeemableOrdinarySharesMember 2025-01-01 2025-09-30 0002026767 us-gaap:CommonStockMember 2025-12-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002026767 us-gaap:RetainedEarningsMember 2025-12-31 0002026767 us-gaap:CommonStockMember 2026-03-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002026767 us-gaap:RetainedEarningsMember 2026-03-31 0002026767 2026-03-31 0002026767 us-gaap:CommonStockMember 2026-06-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002026767 us-gaap:RetainedEarningsMember 2026-06-30 0002026767 2026-06-30 0002026767 us-gaap:CommonStockMember 2024-12-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002026767 us-gaap:RetainedEarningsMember 2024-12-31 0002026767 2024-12-31 0002026767 us-gaap:CommonStockMember 2025-03-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002026767 us-gaap:RetainedEarningsMember 2025-03-31 0002026767 2025-03-31 0002026767 us-gaap:CommonStockMember 2025-06-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002026767 us-gaap:RetainedEarningsMember 2025-06-30 0002026767 2025-06-30 0002026767 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002026767 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002026767 2026-01-01 2026-03-31 0002026767 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002026767 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002026767 2026-04-01 2026-06-30 0002026767 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002026767 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002026767 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002026767 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002026767 2025-01-01 2025-03-31 0002026767 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002026767 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002026767 2025-04-01 2025-06-30 0002026767 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002026767 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002026767 us-gaap:CommonStockMember 2026-09-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002026767 us-gaap:RetainedEarningsMember 2026-09-30 0002026767 us-gaap:CommonStockMember 2025-09-30 0002026767 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002026767 us-gaap:RetainedEarningsMember 2025-09-30 0002026767 2025-09-30 0002026767 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0002026767 us-gaap:RelatedPartyMember 2025-01-01 2025-09-30 0002026767 us-gaap:NonrelatedPartyMember 2026-01-01 2026-09-30 0002026767 us-gaap:NonrelatedPartyMember 2025-01-01 2025-09-30 0002026767 us-gaap:IPOMember 2025-10-23 2025-10-23 0002026767 us-gaap:PrivatePlacementMember 2025-10-23 2025-10-23 0002026767 ALIS:EarlyBirdCapitalIncMember 2025-10-23 2025-10-23 0002026767 us-gaap:IPOMember 2025-10-23 0002026767 2025-10-23 2025-10-23 0002026767 2025-01-01 2025-12-31 0002026767 ALIS:RedeemableOrdinarySharesMember 2025-07-01 2025-09-30 0002026767 ALIS:RedeemableOrdinarySharesMember 2025-01-01 2025-09-30 0002026767 2025-04-01 2025-09-30 0002026767 us-gaap:FairValueInputsLevel1Member 2026-09-30 0002026767 us-gaap:FairValueInputsLevel2Member 2026-09-30 0002026767 us-gaap:FairValueInputsLevel3Member 2026-09-30 0002026767 us-gaap:FairValueInputsLevel1Member 2025-12-31 0002026767 us-gaap:FairValueInputsLevel2Member 2025-12-31 0002026767 us-gaap:FairValueInputsLevel3Member 2025-12-31 0002026767 us-gaap:OverAllotmentOptionMember 2025-10-23 2025-10-23 0002026767 us-gaap:PrivatePlacementMember 2025-10-23 0002026767 us-gaap:PrivatePlacementMember ALIS:SponsorsMember 2025-10-23 2025-10-23 0002026767 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2025-10-23 2025-10-23 0002026767 ALIS:SponsorsMember ALIS:FounderSharesMember 2024-03-21 2024-03-21 0002026767 ALIS:SponsorsMember 2024-03-21 2024-03-21 0002026767 ALIS:SponsorsMember ALIS:FounderSharesMember 2025-06-01 2025-06-30 0002026767 ALIS:FounderSharesMember 2025-06-01 2025-06-30 0002026767 ALIS:SponsorsMember us-gaap:OverAllotmentOptionMember ALIS:FounderSharesMember 2025-06-01 2025-06-30 0002026767 ALIS:SponsorsMember us-gaap:OverAllotmentOptionMember ALIS:FounderSharesMember 2025-01-01 2025-12-31 0002026767 ALIS:FounderSharesMember 2025-12-31 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2024-04-02 2024-04-02 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2024-04-02 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-06-25 2025-06-25 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-06-25 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-09-30 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-12-31 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2024-04-01 2024-04-30 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2024-04-30 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-06-01 2025-06-30 0002026767 ALIS:EarlyBirdCapitalIncMember ALIS:FounderSharesMember 2025-06-30 0002026767 ALIS:SponsorMember 2026-09-01 2026-09-30 0002026767 us-gaap:IPOMember 2026-10-23 0002026767 ALIS:SponsorMember 2026-10-23 2026-10-23 0002026767 ALIS:SubscriptionAgreementMember ALIS:SponsorMember 2026-07-31 2026-07-31 0002026767 ALIS:SubscriptionAgreementMember ALIS:SponsorMember 2026-07-31 0002026767 2024-04-02 2024-04-02 0002026767 2025-06-25 2025-06-25 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-04-02 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-25 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2024-04-02 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2025-06-25 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2024-04-02 0002026767 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-25 0002026767 us-gaap:FairValueInputsLevel3Member ALIS:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2024-04-02 0002026767 us-gaap:FairValueInputsLevel3Member ALIS:MeasurementInputProbabilityOfCompletionOfBusinessCombinationMember 2025-06-25 0002026767 us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002026767 ALIS:BusinessCombinationMarketingAgreementMember 2026-01-01 2026-09-30 0002026767 ALIS:BusinessCombinationMarketingAgreementMember 2026-09-30 0002026767 us-gaap:OverAllotmentOptionMember 2025-06-01 2025-06-30 0002026767 us-gaap:OverAllotmentOptionMember 2025-10-27 2025-10-27 0002026767 ALIS:FounderSharesMember 2026-01-01 2026-09-30 0002026767 ALIS:BusinessCombinationAgreementMember us-gaap:CommonStockMember 2026-03-06 2026-03-06 0002026767 ALIS:BusinessCombinationAgreementMember 2026-03-06 2026-03-06 0002026767 ALIS:PrepaidForwardPurchaseAgreementMember 2026-09-15 2026-09-15 0002026767 ALIS:PrepaidForwardPurchaseAgreementMember us-gaap:SubsequentEventMember 2026-10-13 2026-10-13 0002026767 ALIS:SubscriptionAgreementsMember us-gaap:CommonClassAMember 2026-04-30 2026-04-30 0002026767 ALIS:SubscriptionAgreementsMember us-gaap:CommonClassAMember 2026-04-30 0002026767 ALIS:GoodvisionVenturesLPMember ALIS:SubscriptionAgreementsMember 2026-07-31 2026-07-31 0002026767 ALIS:CordovaFinanceLPMember ALIS:SubscriptionAgreementsMember 2026-07-31 2026-07-31 0002026767 ALIS:CalisaHoldingLPMember ALIS:SubscriptionAgreementsMember 2026-07-31 2026-07-31 0002026767 ALIS:SubscriptionAgreementsMember ALIS:GoodvisionVenturesLPMember 2026-07-31 0002026767 ALIS:SubscriptionAgreementsMember ALIS:CordovaFinanceLPMember 2026-07-31 0002026767 ALIS:SubscriptionAgreementsMember ALIS:CalisaHoldingLPMember 2026-07-31 0002026767 ALIS:SingleReportableSegmentMember 2026-01-01 2026-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ALIS:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________

 

Commission File Number: 001-42910

 

Calisa Acquisition Corp

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A
(State or other jurisdiction   (IRS Employer
of incorporation or organization)   Identification Number)

 

205 W 37th St, New York, NY   10018
(Address of principal executive offices)   (Zip code)

 

(203) 998-5540

(Issuer’s telephone number including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share and one right   ALISU   The Nasdaq Stock Market LLC
Ordinary Shares, par value $0.000075 per share   ALIS   The Nasdaq Stock Market LLC
Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company’s initial business combination   ALISR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒Yes ☐No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

  Large accelerated filer ☐ Accelerated filer ☐  
  Non-accelerated filer ☒ Smaller reporting company ☒  
    Emerging growth company ☒  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of November 13, 2026, the registrant had 8,427,500 ordinary shares, $0.000075 par value, outstanding.

 

 

 

 

 

 

  INDEX
Part I - Financial Information 2
   
Item 1 – Financial Statements 2
   
Consolidated Balance Sheets (Unaudited) 2
   
Consolidated Statements of Operations (Unaudited) 3
   
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) 4
   
Consolidated Statements of Cash Flows (Unaudited) 5
   
Notes to Unaudited Consolidated  Financial Statements 6
   
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
   
Item 3 – Quantitative and Qualitative Disclosures About Market Risk 16
   
Item 4 – Controls and Procedures 16
   
Part II - Other Information 17
   
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds 17
   
Item 5 – Other Information 17
   
Item 6 – Exhibits 18
   
Signatures 19

 

1

 

 

Part I - Financial Information

 

Item 1 – Financial Statements

 

CALISA ACQUISITION CORP

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

   September 30, 2026   December 31, 2025 
         
Assets          
Cash and cash equivalents  $195,720   $459,048 
Prepaid expenses   55,148    129,174 
Total current assets   250,868    588,222 
           
Cash and Investments held in trust   62,062,113    60,429,224 
Total assets  $62,312,981   $61,017,446 
           
Liabilities and Shareholders’ Equity          
Accounts payable  $98,145   $- 
Accrued expenses   -    15 
Accrued offering costs   75,000    78,973 
Accrued expenses - related party   -    6,198 
Total current liabilities   173,145    85,186 
Total liabilities   173,145    85,186 
           
Commitments and contingencies          
Ordinary shares subject to possible redemption, 6,000,000 shares at redemption value of $10.34 and $10.07 per share as of September 30, 2026 and December 31, 2025, respectively   62,062,113    60,429,224 
           
Shareholders’ Equity:          
Preference shares, $0.000075 par value; 2,666,666 shares authorized; none issued and outstanding   -    - 
Ordinary shares, $0.000075 par value; 266,666,666 shares authorized; 2,427,500 shares issued and outstanding as of September 30, 2026 and December 31, 2025 (excluding 6,000,000 shares subject to possible redemption)   182    182 
Additional paid-in capital   -    336,822 
Retained earnings   77,541    166,032 
Total shareholders’ equity   77,723    503,036 
Total Liabilities and Shareholders’ Equity  $62,312,981   $61,017,446 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

2

 

 

CALISA ACQUISITION CORP

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

             
   FOR THE THREE
MONTHS ENDED
SEPTEMBER 30,
   FOR THE NINE
MONTHS ENDED
SEPTEMBER 30,
 
   2026   2025   2026   2025 
                 
Formation and operating costs  $(229,798)  $(61,800)  $(987,178)  $(84,533)
Loss from operations   (229,798)   (61,800)   (987,178)   (84,533)
                     
Other income                    
Bank interest income   1,854    17    7,366    47 
Interest earned on cash and investments held in Trust Account   561,951    -    1,632,889    - 
Total other income   563,805    17    1,640,255    47 
                     
Net income (loss)  $334,007   $(61,783)  $653,077   $(84,486)
                     
Weighted average ordinary shares outstanding, ordinary shares subject to possible redemption   6,000,000    -    6,000,000    - 
Basic and diluted net income (loss) per share, ordinary shares subject to redemption  $0.04   $-   $0.08   $- 
                     
Weighted average ordinary shares outstanding, ordinary shares, non-redeemable   2,427,500    2,175,000    2,427,500    2,148,291 
Basic and diluted net income (loss) per share, ordinary shares, non-redeemable  $0.04   $(0.03)  $0.08   $(0.04)

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

3

 

 

CALISA ACQUISITION CORP

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(UNAUDITED)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

 

   Shares** ^             
   Ordinary Shares   Additional
Paid-in
   Retained   Shareholders’ 
   Shares   Amount   Capital   earnings   Equity 
Balance as of December 31, 2025   2,427,500   $182   $336,822   $166,032   $503,036 
                          
Non-cash expenses paid by target   -    -    94,000    -    94,000 
Subsequent measurement of ordinary shares subject to possible redemption   -    -    (430,822)   (100,528)   (531,350)
Net loss   -    -    -    (53,287)   (53,287)
Balance as of March 31, 2026   2,427,500   $182   $-   $12,217   $12,399 
                          
Non-cash expenses paid by target   -    -    357,009    -    357,009 
Subsequent measurement of ordinary shares subject to possible redemption   -    -    (357,009)   (182,579)   (539,588)
Net income   -    -    -    372,357    372,357 
Balance as of June 30, 2026   2,427,500   $182   $-   $201,995   $202,177 
                          
Non-cash expenses paid by target   -    -    103,490    -    103,490 
Subsequent measurement of ordinary shares subject to possible redemption   -    -    (103,490)   (458,461)   (561,951)
Net income   -    -    -    334,007    334,007 
Balance as of September 30, 2026   2,427,500   $182   $-   $77,541   $77,723 

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

 

   Ordinary Shares   Additional
Paid-in
   Accumulated   Shareholders’
Equity
 
   Shares   Amount   Capital   Deficit   (Deficit) 
                         
Balance as of December 31, 2024   2,433,333   $183   $152,817   $(79,422)  $      73,578 
                          
Net loss   -    -    -    -    - 
Balance as of March 31, 2025   2,433,333   $183   $152,817   $(79,422)  $73,578 
                          
Issuance of ordinary shares to underwriter   41,667    3    48,331    -    48,334 
Net loss   -    -    -    (22,703)   (22,703)
Balance as of June 30, 2025   2,475,000   $186   $201,148   $(102,125)  $99,209 
Net loss   -    -    -    (61,783)   (61,783)
Balance as of September 30, 2025   2,475,000   $186   $201,148   $(163,908)  $37,426 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

4

 

 

CALISA ACQUISITION CORP

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

  

FOR THE NINE
MONTHS ENDED
September 30,

2026

  

FOR THE NINE
MONTHS ENDED
September 30,

2025

 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $653,077   $(84,486)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Non-cash expenses paid by target   554,499    - 
Interest earned on cash and investments held in Trust Account   (1,632,889)     
Changes in current assets and liabilities:          
Prepaid expense   74,026    2,133 
Accounts Payable   98,145    - 
Accrued expenses – related party   (6,198)   - 
Accrued expenses   (15)   (41,253)
Accrued offering costs   -    - 
Net cash used in operating activities   (259,355)   (123,606)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from due to related party   -    123,653 
Proceeds from other payable – related party   -    1,900,000 
Proceeds from issuance of ordinary shares to EBC   -    454 
Payment of accrued IPO offering costs   (3,973)   - 
Net cash provided by (used in) financing activities   (3,973)   2,024,107 
           
Net increase (decrease) in cash and cash equivalents   (263,328)   1,900,501 
Cash and cash equivalents at beginning of period   459,048    1,487 
Cash and cash equivalents at end of period  $195,720   $1,901,988 
           
Supplemental disclosure of noncash investing and financing activities          
Deferred offering costs charged to additional paid-in capital – EBC founder shares   -    47,880 
Deferred offering costs paid by related party   -    25,089 
Deferred offering costs included in accrued expenses   -    2,452 
Expenses paid by target and recorded as capital contribution   554,499    - 
Subsequent measurement of ordinary shares subject to possible redemption   1,632,889    - 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

5

 

 

CALISA ACQUISITION CORP

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — ORGANIZATION AND BUSINESS OPERATIONS

 

Calisa Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on March 11, 2024. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”).

 

The Company is an early stage and emerging growth company and is subject to the risks associated with early stage and emerging growth companies. The Company’s sponsors are Alisa Group Limited, a British Virgin Islands company, and Calisa Holding LP, a Delaware limited partnership (the “Sponsors”). All activity from inception through September 30, 2026 relates to the Company’s formation, its initial public offering (“IPO”) and the proposed Business Combination with Goodvision AI Inc. (“Goodvision”), as described in Note 8.

 

On February 24, 2026, Calisa Merger Sub, a Cayman Islands exempted company and wholly owned subsidiary of the Company (“Merger Sub”), was formed for purposes of the proposed Business Combination. Merger Sub has no principal operations or revenue-producing activities. As of September 30, 2026, the Company had not commenced any revenue-generating operations and expects to generate non-operating income from the proceeds held in the Trust Account. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s IPO was declared effective on October 20, 2025. On October 23, 2025, the Company consummated the IPO of 6,000,000 units, generating gross proceeds of $60,000,000, and simultaneously sold 252,500 private placement units to the Sponsors and EarlyBirdCapital, Inc. (“EBC”) for gross proceeds of $2,525,000.

 

Transaction costs related to the IPO amounted to $1,960,106, consisting of $1,200,000 of cash underwriting fees and $760,106 of other offering costs. The total includes $2,521 of additional IPO costs invoiced after the IPO closing, which were recorded as a reduction of additional paid-in capital with a corresponding increase in accrued expenses. Upon completion of the IPO, $1,930,704 of offering costs allocated to the Public Shares was charged against the carrying value of ordinary shares subject to possible redemption, and $29,402 allocated to the Public Rights was charged to additional paid-in capital, as described in Note 2.

 

The Company will have until April 23, 2027 to consummate a Business Combination (the “Combination Period”). If the Company has not completed a Business Combination within the Combination Period and has not sought to have shareholders amend the Combination Period to provide for additional time to complete such transaction, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to pay taxes, if any (less certain amount of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Trust Account

 

On October 23, 2025, $60,000,000 of the net proceeds from the IPO and the sale of the Private Placement Units was deposited into a trust account (the “Trust Account”). The funds may be held as cash or invested in qualifying U.S. government securities or qualifying money market funds until the earlier of the completion of a Business Combination or distribution of the Trust Account to shareholders. Amounts may be released to pay taxes and certain permitted working capital and dissolution expenses.

 

Going Concern Consideration

 

As of September 30, 2026, the Company had $195,720 of cash and cash equivalents outside the Trust Account and working capital of $77,723, compared with $459,048 of cash and cash equivalents and working capital of $503,036 as of December 31, 2025. The Company has incurred, and expects to continue to incur, significant public-company and transaction expenses in pursuit of the proposed Business Combination.

 

6

 

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-40, Presentation of Financial Statements—Going Concern, management has determined that the Company’s available liquidity, expected public-company and transaction expenses and mandatory liquidation date of April 23, 2027 raise substantial doubt about the Company’s ability to continue as a going concern; the plans described below do not alleviate that substantial doubt. Management’s evaluation considered the Company’s mandatory liquidation and subsequent dissolution if a Business Combination is not completed within the Combination Period.

 

The April 23, 2027 mandatory liquidation date is within one year after the expected issuance date of these financial statements. Management’s plans include pursuing the proposed Business Combination and the related conditional subscription arrangements described in Note 8. Those subscriptions are contingent on closing and do not provide funds for pre-closing operating expenses. There is no assurance that the Company will complete a Business Combination within the Combination Period. The accompanying unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments consisting of normal recurring accruals necessary for a fair presentation have been included. These interim financial statements should be read in conjunction with the Company’s audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2025. Interim results are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future interim periods. 

 

Principles of Consolidation

 

The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany transactions and balances have been eliminated in consolidation.

 

Emerging Growth Company

 

The Company is an “emerging growth company” (“EGC”), as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and may take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies.

 

These exemptions include, among others, an exemption from the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation, and exemptions from the requirements to hold nonbinding advisory votes on executive compensation and shareholder approval of certain golden parachute payments.

 

Section 102(b)(1) of the JOBS Act provides that an EGC may take advantage of an extended transition period for complying with new or revised accounting standards. The Company has elected not to opt out of the extended transition period.

 

As a result, the Company’s financial statements may not be comparable to companies that comply with public company effective dates for new or revised accounting standards.

 

Use of Estimates

 

The preparation of the unaudited consolidated financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents were $195,720 and $459,048 as of September 30, 2026 and December 31, 2025, respectively.

 

Cash and Investments Held in Trust Account

 

As of September 30, 2026 and December 31, 2025, the Company had $62,062,113 and $60,429,224, respectively, held in the Trust Account, which is presented as “Cash and Investments held in Trust Account” on the accompanying consolidated balance sheets.

 

Cash and investments held in the Trust Account were comprised of money market funds that invest in U.S. government securities. Investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Earnings on cash and investments held in the Trust Account are included in interest earned on cash and investments held in the Trust Account in the accompanying statement of operations. The estimated fair value of cash and investments held in the Trust Account is determined using available market information.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash maintained in financial institutions, which at times may exceed Federal Deposit Insurance Corporation (“FDIC”) insurance limits.

 

As of September 30, 2026 and December 31, 2025, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant credit risk related to these accounts.

 

However, any loss incurred or lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.

 

Offering Costs Associated with the IPO

 

The Company applies ASC 340-10-S99-1 (SAB Topic 5.A, “Expenses of Offering”) in accounting for offering costs. Offering costs consisted principally of legal, accounting, underwriting and other costs directly related to the IPO. These costs were allocated to the separable financial instruments issued in the IPO based on their relative fair values.

 

Upon completion of the IPO, offering costs allocated to the Public Shares were charged against the carrying value of ordinary shares subject to possible redemption, and offering costs allocated to the Public Rights were charged to additional paid-in capital. See Note 3 for additional detail regarding the IPO structure and Note 1 for related offering costs.

 

7

 

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with ASC 480, Distinguishing Liabilities from Equity. Ordinary shares that are subject to mandatory redemption are classified as liabilities and measured at fair value. Conditionally redeemable ordinary shares— including shares with redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control—are classified as temporary equity.

 

The Company’s Public Shares include redemption features that are considered to be outside the Company’s control and, therefore, are classified as ordinary shares subject to possible redemption. As of September 30, 2026 and December 31, 2025, ordinary shares subject to possible redemption of $62,062,113 and $60,429,224 are presented as temporary equity outside of shareholders’ equity respectively.

 

Immediately upon the closing of the IPO, the Company recognized accretion from the initial carrying value of the ordinary shares subject to possible redemption to their redemption value. Thereafter, the Company recognizes changes in redemption value as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Adjustments to the carrying amount are recorded as charges to additional paid-in capital, or to accumulated deficit if additional paid-in capital is not available.

 

As of September 30, 2026 and December 31, 2025, ordinary shares subject to possible redemption are reconciled as follows:

 

      
Gross Proceeds  $60,000,000 
Less:     
Gross proceeds allocated to Public Rights   (874,000)
Offering costs allocated to Public Shares   (1,930,704)
Add:     
Remeasurement of carrying value to redemption value   3,233,928 
Ordinary shares subject to possible redemption, as of December 31, 2025  $60,429,224 
      
Plus:     
Subsequent measurement of ordinary shares subject to possible redemption   1,632,889 
Ordinary shares subject to possible redemption, as of September 30, 2026  $62,062,113 

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited consolidated financial statements.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Remeasurement of carrying value to redemption value of redeemable ordinary shares is excluded from income (loss) per share as the redemption value approximates fair value.

 

For the three and nine months ended September 30, 2026, the Company has not considered the effect of the Rights included in the IPO and Private Placement Units in the calculation of diluted net income (loss) per share, since the conversion of the Rights is contingent upon the occurrence of future events and the inclusion of such Rights would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following:

 

   2026   2025   2026   2025 
  

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2026   2025   2026   2025 
Net income (loss)  $334,007   $(61,783)  $653,077   $(84,486)
Allocation of net income – redeemable  $237,798   $-   $464,961   $- 
Allocation of net income (loss) – non-redeemable  $96,209   $(61,783)  $188,116   $(84,486)
Weighted-average shares outstanding – redeemable   6,000,000    -    6,000,000    - 
Basic and diluted net income per share – redeemable  $0.04   $-   $0.08   $- 
Weighted-average shares outstanding – non-redeemable   2,427,500    2,175,000    2,427,500    2,148,291 
Basic and diluted net income (loss) per share – non-redeemable  $0.04   $(0.03)  $0.08   $(0.04)

 

8

 

 

Fair Value of Financial Instruments

 

The carrying values of the Company’s financial instruments, which are primarily short-term in nature, approximate fair value. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used in valuation techniques used to measure fair value, giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

 

Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities. Investments held in the Trust Account that are measured at fair value (such as money market funds investing in U.S. government securities) are generally classified within Level 1.

 

Level 2 — inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3 — unobservable inputs for the asset or liability. The following tables present the carrying amounts of the Company’s financial assets as of September 30, 2026 and December 31, 2025 and indicate the fair value hierarchy for assets measured at fair value on a recurring basis. Cash and cash equivalents are carried at cost and are excluded from the fair value hierarchy.

 

       Quoted   Significant   Significant 
       Prices in   Other   Other 
   As of   Active   Observable   Unobservable 
   September 30,   Markets   Inputs   Inputs 
   2026   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Cash and investments held in Trust Account  $62,062,113   $62,062,113   $-   $- 

 

       Quoted   Significant   Significant 
       Prices in   Other   Other 
   As of   Active   Observable   Unobservable 
   December 31,   Markets   Inputs   Inputs 
   2025   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Cash and investments held in Trust Account  $60,429,224   $60,429,224   $-   $- 

 

Recent Accounting Standards

 

Management evaluates newly issued accounting standards on an ongoing basis to determine their potential impact on the Company’s financial statements.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), requiring public entities to disclose additional information about specified expense categories on an annual and interim basis. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the impact of adoption.

 

NOTE 3 — INITIAL PUBLIC OFFERING

 

On October 23, 2025, pursuant to the Company’s IPO, the Company sold 6,000,000 Units at a price of $10.00 per Unit, generating gross proceeds of $60,000,000. Each Unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial Business Combination (each, a “Right”). Ten Rights entitle the holder to receive one ordinary share (see Note 7). The Company will not issue fractional shares and only whole shares will trade; accordingly, unless a holder holds Rights in multiples of ten, such holder will not be able to receive or trade the fractional shares underlying the Rights.

 

The Company granted the underwriters a 45-day option to purchase up to an additional 900,000 Units to cover over-allotments (the “Over-Allotment Option”). On October 27, 2025, the underwriters delivered a termination notice indicating that the Over-Allotment Option would not be exercised.

 

NOTE 4 — PRIVATE PLACEMENTS

 

Simultaneously with the closing of the IPO on October 23, 2025, the Sponsors and EBC purchased an aggregate of 252,500 Private Placement Units at $10.00 per unit, generating gross proceeds of $2,525,000. The Sponsors purchased 192,500 Private Placement Units for $1,925,000, and EBC and/or its designees purchased 60,000 Private Placement Units for $600,000. Each Private Placement Unit consists of one ordinary share and one right, and ten Private Rights entitle the holder to receive one ordinary share upon completion of the Company’s initial Business Combination. The Private Placement Units and underlying securities are subject to transfer restrictions until completion of a Business Combination, subject to certain exceptions.

 

NOTE 5 — RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On March 21, 2024, the Sponsors purchased 1,725,000 ordinary shares (the “Founder Shares”) for an aggregate purchase price of $25,000, representing deferred offering costs paid by the Sponsors on behalf of the Company. Up to 225,000 Founder Shares were subject to forfeiture to the extent the underwriters’ over-allotment option was not exercised in full.

 

In June 2025, the Company effected a 4-for-3 stock split of its outstanding shares, resulting in an aggregate of 2,300,000 Founder Shares outstanding. All share and per-share amounts have been retroactively adjusted to reflect the stock split. Following the stock split, up to 300,000 Founder Shares were subject to forfeiture to the extent the underwriters’ over-allotment option was not exercised in full.

 

The underwriters did not exercise the over-allotment option and delivered an over-allotment termination letter dated October 27, 2025. Accordingly, the 300,000 Founder Shares that were subject to forfeiture were forfeited as of December 31, 2025. As of September 30, 2026 and December 31, 2025, the Company had 2,000,000 Founder Shares issued and outstanding (excluding Private Placement Shares and EBC Founder Shares).

 

EBC Founder Shares

 

On April 2, 2024, the Company issued 100,000 ordinary shares to EBC (the “EBC Founder Shares”) for a purchase price of $0.0145 per share (aggregate purchase price of $1,450). As a result of the stock split described above, the EBC Founder Shares became an aggregate of 133,333 EBC Founder Shares.

 

On June 25, 2025, the Company issued an additional 41,667 EBC Founder Shares to EBC for a purchase price of $0.0109 per share and an aggregate purchase price of $454. As of September 30, 2026 and December 31, 2025, there were 175,000 EBC Founder Shares issued and outstanding.

 

The EBC Founder Shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company estimated the fair value of the EBC Founder Shares issued in April 2024 to be approximately $128,000 (or $0.96 per share) and the EBC Founder Shares issued in June 2025 to be approximately $48,334 (or $1.16 per share) using the Black-Scholes option-pricing model.

 

The Company accounted for the excess of the estimated fair value over the purchase price of the EBC Founder Shares as deferred offering costs. For the EBC Founder Shares issued in June 2025, deferred offering costs were $47,880, representing the estimated fair value of $48,334 less the $454 purchase price.

 

9

 

 

The fair value of the EBC founder shares was estimated at April 2, 2024 and June 25, 2025. The Company used the following assumptions to estimate the fair value of EBC founder shares using Level 3 fair value measurements inputs at the measurement date:

 

   April 2, 2024   June 25, 2025 
Time to expiration   1.91    1.76 
Risk-free rate   4.7%   3.8%
Volatility   5.0%   4.1%
Dividend yield   0.0%   0.0%
Probability of completion of business combination   13.4%   11.8%

 

Transfer Restrictions

 

The Sponsors have agreed, subject to limited exceptions, that the Founder Shares will not be transferred, assigned or sold until the earlier to occur of: (A) six months after the consummation of the Company’s initial business combination or (B) the date on which the Company completes a subsequent liquidation, merger, share exchange, reorganization or other similar transaction following the initial business combination that results in all shareholders having the right to exchange their shares for cash, securities or other property.

 

EBC has also agreed that the EBC Founder Shares may not be sold, transferred or assigned (except to the same permitted transferees as the Founder Shares, and provided that such transferees agree to the same terms and restrictions) until the consummation of the Company’s initial business combination.

 

Other Payable – Related Party

 

In September 2025, the Company received $1.9 million from Sponsors for the private placement units which related to the IPO which closed on October 23, 2025. $1.7 million was deposited into the Trust on the closing of the IPO in October on behalf of the Sponsors, and the remaining $0.2 million representing an overfunded amount was returned to the Sponsors.

 

Due to Related Party

 

The Sponsors paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest bearing.

 

For the three months ended September 30, 2026 and 2025, the Sponsors advanced $0 and approximately $72,339, respectively, to the Company.

 

For the nine months ended September 30, 2026 and 2025, the Sponsors provided no new cash advances in 2026 and approximately $151,194 of cash funding in 2025.

 

As of September 30, 2026 and December 31, 2025, there were no amounts due to the Sponsors. 

 

Accounting and Advisory Services — Related Party

 

The Company previously engaged Ascendant Global Advisors Inc. (“Ascendant”), an affiliate of Calisa Holding LP, to provide accounting and SEC reporting support. The agreement was terminated in November 2025, and the Company no longer incurs fees under the arrangement.

 

For the three and nine months ended September 30, 2026 and 2025, the Company did not incur fees under this arrangement. Accrued expenses — related party related to Ascendant were $0 as of September 30, 2026 and $6,198 as of December 31, 2025.

 

Administration Fee — Related Party

 

Beginning on the effective date of the registration statement for the IPO, Calisa Holding LP is permitted to charge the Company an allocable share of its overhead, up to $10,000 per month, to compensate it for the Company’s use of office space, utilities and personnel until the completion of a business combination. The Company incurred administration fees of $30,000 and $0 for the three months ended September 30, 2026 and 2025, respectively, and $90,000 and $0 for the nine months ended September 30, 2026 and 2025, respectively.

 

As of September 30, 2026 and December 31, 2025, there were no amounts payable related to the administration fee.

 

Subscription Agreement — Related Party

 

On July 31, 2026, Calisa Holding LP, a Sponsor, entered into a subscription agreement with the Company and Goodvision to purchase 250,000 ordinary shares at $10.00 per share for an aggregate purchase price of $2,500,000 immediately before and contingent upon consummation of the Merger. The subscription had not closed, and no amounts were funded, as of September 30, 2026.

 

10

 

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

In connection with the IPO, the Company entered into a registration rights agreement with the holders of the Founder Shares, EBC Founder Shares, Private Placement Units and any Units that may be issued upon conversion of working capital loans (and the underlying securities), pursuant to which such holders are entitled to registration rights requiring the Company to register such securities for resale.

 

The holders are entitled to make up to three demand registrations (excluding “short-form” registration demands). In addition, the holders have “piggyback” registration rights with respect to registration statements filed following the completion of a Business Combination and the right to require the Company to register such securities for resale pursuant to Rule 415 under the Securities Act. However, the Company is not required to effect or permit any registration statement to become effective until the applicable securities are released from their lock-up restrictions.

 

In compliance with FINRA Rule 5110(g)(8), the registration rights granted to EBC are limited to demand and piggyback rights for periods of five and seven years, respectively, from the commencement of sales in the IPO, and EBC may only exercise its demand rights on one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of the IPO to purchase up to 900,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The underwriters did not exercise the over-allotment option and delivered an over-allotment termination letter dated October 27, 2025.

 

The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $1,200,000 in the aggregate, which was paid at the closing of the IPO. The cash underwriting discount is included in offering costs (see Notes 1 and 2).

 

Business Combination Marketing Agreement

 

The Company engaged EBC to provide advisory services in connection with the Company’s initial Business Combination, including assisting with shareholder meetings and communications, introducing the Company to potential investors, supporting the shareholder approval process, and assisting with press releases and certain public filings related to the Business Combination.

 

Upon consummation of the Company’s initial Business Combination, the Company is obligated to pay EBC a success fee equal to 3.5% of the gross proceeds of the IPO (or $2,100,000), consisting of (i) 1.5% payable in cash (or $900,000) and (ii) 2.0% payable, at the Company’s option, in a convertible note with customary terms that is convertible into ordinary shares six months after consummation (or $1,200,000). If the Company does not complete an initial Business Combination, no success fee will be due. In addition, if the Company consummates its initial Business Combination with a target introduced by EBC, the Company will pay EBC a finder’s fee equal to 1.0% of the consideration issued to such target. As of the filing date, no such service has been provided by EBC.

 

Because these fees are contingent upon consummation of an initial Business Combination, no liability was recorded as of September 30, 2026 or December 31, 2025. The Company will evaluate recognition under ASC 450 as facts and circumstances change, including whether the consummation of an initial Business Combination becomes probable and the amounts are reasonably estimable.

 

Risks and Uncertainties

 

The Company’s ability to consummate an initial Business Combination may be adversely affected by volatility in credit and capital markets, inflation, supply chain disruptions, geopolitical instability and related sanctions or governmental actions. These factors could adversely affect the Company’s search for and consummation of an initial Business Combination and the operations of a target business. The unaudited consolidated financial statements do not include adjustments that might result from the outcome of these uncertainties.

 

11

 

 

NOTE 7 — SHAREHOLDERS’ EQUITY

 

Preference Shares — The Company is authorized to issue 2,666,666 preference shares with a par value of $0.000075 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Ordinary Shares — The Company is authorized to issue 266,666,666 ordinary shares with a par value of $0.000075 per share. Holders of ordinary shares are entitled to one vote for each share.

 

In June 2025, the Company effected a 4-for-3 forward split of the outstanding shares. All share amounts have been retroactively adjusted. On October 23, 2025, in connection with the IPO, the Company issued 6,000,000 Public Shares, which are classified as ordinary shares subject to possible redemption and are presented as temporary equity (see Notes 2 and 3)

 

Up to 300,000 Founder Shares were subject to forfeiture to the extent the underwriters’ over-allotment option was not exercised, in order for the Founder Shares to equal 25% of the Company’s issued and outstanding ordinary shares after the IPO (excluding Private Placement Shares and EBC Founder Shares). The underwriters did not exercise the over-allotment option and delivered an over-allotment termination letter on October 27, 2025; accordingly, 300,000 Founder Shares were forfeited.

 

As of September 30, 2026 and December 31, 2025, there were 2,427,500 ordinary shares issued and outstanding (excluding the Public Shares classified as temporary equity described above).

 

Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right is entitled to receive one-tenth (1/10) of one ordinary share upon consummation of the Company’s initial business combination. Rights will only convert into a whole number of ordinary shares; accordingly, holders must have ten (10) Rights to receive one (1) ordinary share.

 

The Company does not issue fractional shares in connection with the conversion of Rights. Any fractional shares that would otherwise be issuable will be rounded down to the nearest whole share (or otherwise addressed in accordance with the applicable provisions of Cayman law).

 

In the event the Company is not the surviving company upon completion of the initial business combination, each holder of a Right is required to affirmatively convert such Right in order to receive the one-tenth (1/10) of one ordinary share underlying each Right upon consummation of the business combination. If the Company does not complete an initial business combination within the required time period and the Company redeems the Public Shares for the funds held in the Trust Account, holders of Rights are not entitled to any redemption proceeds with respect to such Rights, and the Rights will expire worthless.

 

Other — Transaction Costs Paid on Behalf of the Company

 

Pursuant to the Business Combination Agreement, the target paid transaction-related expenses on the Company’s behalf totaling $103,490 and $554,499 during the three and nine months ended September 30, 2026, respectively. Because the Company has no obligation to repay these amounts, they were recorded as capital contributions with an offset to additional paid-in capital.

 

NOTE 8 – BUSINESS COMBINATION AGREEMENT

 

On March 6, 2026 (the “Execution Date”), the Company entered into a Business Combination Agreement (the “BCA”) with Calisa Merger Sub, a Cayman Islands exempted company and a direct, wholly owned subsidiary of the Company (“Merger Sub”), and Goodvision AI Inc., a Cayman Islands exempted company (“Goodvision”).

 

Pursuant to the terms of the BCA, Merger Sub will merge with and into Goodvision (the “Merger” or the “Target”), with Goodvision surviving the Merger as a direct, wholly owned subsidiary of the Company in accordance with the Companies Act (As Revised) of the Cayman Islands, as amended (the “Companies Act”).

 

The Merger and the other transactions contemplated by the BCA may be consummated following satisfaction or waiver of the remaining closing conditions set forth in the BCA (the “Closing”) and described herein. There is no assurance that the Company will complete a Business Combination within the Combination Period. The Company’s Registration Statement on Form S-4 was declared effective on September 11, 2026. See Note 10 for shareholder approval and other events after September 30, 2026.

 

Pursuant to the Merger, each ordinary share of Goodvision (“Goodvision Share”) (other than treasury shares and dissenting shares) issued and outstanding as of immediately prior to the effective time of the Merger (the “Effective Time”) will be automatically canceled and extinguished and converted into the right to receive a number of ordinary shares of the Company (“SPAC Shares”) equal to 18,000,000 divided by the number of fully diluted Goodvision Shares outstanding (the “Per Share Merger Consideration”). In order to secure certain indemnification obligations of Goodvision described in the BCA, an aggregate of 10% of the aggregate SPAC Shares otherwise issuable as Per Share Merger Consideration (the “Escrow Shares”) will be deposited in escrow.

 

In addition, the Goodvision shareholders will be entitled to receive an additional 3,600,000 SPAC Shares (the “Earnout Shares”) upon satisfaction of the following earnout conditions: (i) 1,800,000 Earnout Shares will be issued if (1) Goodvision achieves net revenue for the fiscal year ended September 30, 2026 in excess of $19.9 million, and (2) the daily VWAP of the SPAC Shares is greater than or equal to $12.00 per share for any 20 trading days within any 30 consecutive trading day period commencing after the six month anniversary of the Closing and ending before the sixtieth day after the combined company files its annual report for the fiscal year ended September 30, 2027, and (ii) 1,800,000 Earnout Shares will be issued if (1) Goodvision achieves net revenue for the fiscal year ended September 30, 2027 in excess of $106.0 million, and (2) the daily VWAP of the SPAC Shares is greater than or equal to $15.00 per share for any 20 trading days within any 30 consecutive trading day period commencing after the six month anniversary of the Closing and ending before the sixtieth day after the combined company files its annual report for such fiscal year.

 

12

 

 

Upon the Closing of the Merger, Goodvision will become a wholly owned subsidiary of the Company, the Goodvision shareholders will become Company shareholders, and the Company will become a holding company operating the business of Goodvision.

 

Prepaid Forward Purchase Agreement — On September 15, 2026, the Company and Goodvision entered into a Prepaid Forward Purchase Agreement (“FPA”) with investment vehicles managed by Harraden Circle Investments, LLC. Subject to the conditions of the FPA, the investors may purchase up to 3,000,000 existing ordinary shares from holders in the open market or through redemption elections at prices not exceeding the redemption price in connection with the Business Combination. No later than one Exchange Business Day after the closing of the Business Combination, the investors are required to deliver a pricing-date notice specifying the number of shares purchased; the FPA becomes effective one settlement cycle after that pricing date. The prepayment amount equals the number of shares specified in the notice multiplied by the redemption price and is payable directly from the Trust Account one Business Day before closing, after giving effect to shareholder redemptions. The investors waived redemption rights with respect to the purchased shares. The original FPA has a maturity date 12 months after closing, or an earlier date designated by the investors, and provides for optional early termination payments based on the then-applicable reset price and physical settlement at maturity. The prepayment would reduce Trust Account cash otherwise available to the combined company following redemptions; significant redemptions could further reduce the funds available to satisfy the prepayment and other closing obligations. The Company evaluated the FPA under ASC 480 and ASC 815-40. Because the Business Combination had not closed, no pricing-date notice had been delivered, the number of shares and prepayment amount had not been fixed, and no amounts had been funded or settled as of September 30, 2026, the Company accounted for the FPA as an executory contract and recognized no asset or liability at that date. The Company will reassess the accounting upon the closing of the Business Combination and effectiveness of the FPA. See Note 10 for the amendment and restatement executed on October 13, 2026, which provides for 50,000 Commitment Shares purchased by the investors, excluded from the Forward Purchase Shares and included in the Trust Account prepayment.

 

Subscription Agreements — On April 30, 2026, the Company and Goodvision entered into a subscription agreement providing for the issuance of 100,000 ordinary shares at $10.00 per share, for $1,000,000 in gross proceeds, immediately before and contingent upon consummation of the Merger. On July 31, 2026, the Company and Goodvision entered into additional subscription agreements with Goodvision Ventures LP, Cordova Finance L.P. and Calisa Holding LP, a Sponsor, for 300,000 ordinary shares for $3,000,000, 250,000 ordinary shares for $2,500,000 and 250,000 ordinary shares for $2,500,000, respectively, in each case at $10.00 per share and immediately before and contingent upon consummation of the Merger. These subscription arrangements had not closed, and no amounts had been funded, as of September 30, 2026. The investors received related registration rights. Calisa Holding LP’s related-party participation is also disclosed in Note 5.

 

NOTE 9 – SEGMENT INFORMATION

 

ASC 280, Segment Reporting, establishes standards for a public entity to report information about operating segments using the “management approach.” Operating segments are components of an entity for which discrete financial information is available and that are regularly reviewed by the chief operating decision maker (“CODM”) to allocate resources and assess performance. The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, and applied the guidance retrospectively to all periods presented. The adoption did not change the Company’s identification of operating segments.

 

The Company’s CODM has been identified as the Chief Executive Officer (the “CODM”), who reviews operating results on a consolidated basis to allocate resources and assess performance. Accordingly, management has determined the Company has one operating and reportable segment.

 

The CODM assesses performance and allocates resources based on net income (loss), which is reported on the statement of operations. The significant segment expense category regularly provided to the CODM is formation and operating costs. All other segment items included in net income (loss) primarily consist of interest income on investments held in the Trust Account, interest earned on cash held in bank accounts, and income taxes, if any, and are included in the statement of operations and described in the related notes.

 

The CODM regularly reviews formation and operating costs, interest income and consolidated net income (loss) when evaluating resources available to pursue the proposed Business Combination. For the three and nine months ended September 30, 2026 and 2025, the financial performance reviewed by the CODM was as follows:

 

Amounts are in U.S. dollars; columns present the three and nine months ended September 30, 2026 and 2025, respectively. Significant segment expenses comprise formation and operating costs, and other income consists principally of income from investments held in the Trust Account.

 

   Three Months Ended
September 30, 2026
   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2026
   Nine Months Ended
September 30, 2025
 
Formation and operating costs  $(229,798)  $(61,800)  $(987,178)  $(84,533)
Other segment income  $563,805   $17   $1,640,255   $47 
Net income (loss)  $334,007   $(61,783)  $653,077   $(84,486)

 

The measure of segment assets is total assets as reported on the unaudited consolidated balance sheets. Total assets were $62,312,981 and $61,017,446 as of September 30, 2026 and December 31, 2025, respectively. The CODM also monitors cash and investments held in the Trust Account, which were $62,062,113 and $60,429,224 as of those dates, respectively.

 

NOTE 10 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions occurring after September 30, 2026 through the date these unaudited consolidated financial statements were issued.

 

On October 8, 2026, shareholders approved the proposed Business Combination with Goodvision and related proposals at an extraordinary general meeting, including proposals concerning the corporate name, Nasdaq share issuance, governing documents and equity incentive plan. Approval of the transaction does not itself constitute completion of the Merger; remaining closing conditions must be satisfied or waived.

 

On October 13, 2026, the Company, Goodvision and the Harraden Circle investors amended and restated the FPA originally executed September 15, 2026. The amended FPA becomes effective one settlement cycle following the pricing date, which occurs after the closing of the Business Combination when the investors deliver notice of the shares purchased. It provides for purchases of up to 3,000,000 Forward Purchase Shares, 50,000 Commitment Shares purchased by the investors and excluded from the Forward Purchase Shares at closing, and a maturity period of 15 months after closing, subject to the detailed settlement provisions and other terms of the agreement. The Prepayment Amount paid from the Trust Account includes both the Forward Purchase Shares and the 50,000 Commitment Shares. The Company will reimburse the investors’ expenses as provided in the amended FPA, and unsold shares are returned to the Company at maturity. The prepayment and expense reimbursement reduce funds otherwise available to the combined company. As of the date these unaudited consolidated financial statements were issued, the Business Combination had not closed, the amended FPA’s effective date had not occurred, and no prepayment had been funded. The Company has not identified adjustments to the September 30, 2026 financial statements arising from these events.

 

13

 

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

References to the “Company,” “we,” “us” or “our” refer to Calisa Acquisition Corp and its consolidated subsidiary unless the context otherwise requires. The discussion below should be read together with the unaudited consolidated financial statements and related notes. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

 

Overview

 

We are a Cayman Islands exempted company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. We completed our IPO on October 23, 2025 and have not generated operating revenues. Our activities include SEC reporting, public-company compliance and pursuit of the proposed Business Combination with Goodvision.

 

On March 6, 2026, we entered into the BCA with Merger Sub and Goodvision. Merger Sub is expected to merge into Goodvision, which would become our wholly owned subsidiary. In connection with the proposed transaction, we entered into a $1.0 million subscription agreement on April 30, 2026 and additional $8.0 million subscription agreements on July 31, 2026, each conditional upon the Merger closing. We also entered into an FPA with Harraden Circle-managed investors on September 15, 2026. On October 8, 2026, our shareholders approved the proposed Business Combination and related proposals, although the Merger had not closed and remained subject to satisfaction or waiver of the remaining closing conditions. On October 13, 2026, we amended and restated the FPA to provide for purchases of up to 3,000,000 Forward Purchase Shares, 50,000 investor-purchased Commitment Shares excluded from the Forward Purchase Shares but included in the Trust Account prepayment and a 15-month maturity period after closing. The amended FPA becomes effective after closing following delivery of the investors’ pricing-date notice.

 

Results of Operations

 

We have not generated operating revenues. Our income is primarily non-operating interest earned on Trust Account investments and bank deposits, while operating costs consist principally of SEC reporting, legal, accounting, administration and proposed Business Combination expenses. The IPO closed in October 2025, and the 2026 periods therefore include trust interest and public-company and transaction expenses that were not present in the comparable 2025 periods.

 

For the three months ended September 30, 2026, we recognized net income of $334,007, compared with a net loss of $61,783 for the three months ended September 30, 2025. Third-quarter 2026 income consisted of $561,951 of interest earned on cash and investments held in the Trust Account and $1,854 of interest income outside the Trust Account, partially offset by $229,798 of formation and operating costs, an increase of $167,998 from the comparable prior-year quarter. The comparable 2025 quarter included $61,800 of formation and operating costs and $17 of bank interest income.

 

For the nine months ended September 30, 2026, net income was $653,077, compared with a net loss of $84,486 for the same period of 2025. Nine-month 2026 income included $1,632,889 of Trust Account interest and $7,366 of interest on bank deposits, partially offset by $987,178 of formation and operating costs, an increase of $902,645 from the comparable nine-month period of 2025. The corresponding 2025 period included $84,533 of formation and operating costs and $47 of other interest income. The higher operating costs in 2026 were principally attributable to public-company reporting and activities related to the proposed Goodvision Business Combination. Trust Account interest was earned only after the October 2025 IPO. No formation or operating costs were incurred during the three months ended March 31, 2025.

 

Liquidity and Capital Resources

 

On October 23, 2025, we completed the IPO of 6,000,000 Public Units at $10.00 per unit, generating gross proceeds of $60,000,000. Simultaneously, we sold 252,500 Private Placement Units to the Sponsors and EBC at $10.00 per unit for gross proceeds of $2,525,000. The Company deposited $60,000,000 into the Trust Account at closing.

 

As of September 30, 2026, the Trust Account held $62,062,113, compared with $60,429,224 as of December 31, 2025. These amounts are subject to the Public Shareholders’ redemption rights and the terms of the Trust Agreement. We expect available proceeds after any redemptions and transaction costs to be used in the proposed Business Combination and, following closing, by the combined company for working capital and other corporate purposes. The amount of cash ultimately available depends upon shareholder redemptions, expenses and transaction financing arrangements, including the FPA.

 

14

 

 

As of September 30, 2026, we had $195,720 in cash and cash equivalents outside the Trust Account, prepaid expenses of $55,148, total current assets of $250,868 and current liabilities of $173,145, resulting in positive working capital of $77,723. This compares with $459,048 of unrestricted cash and working capital of $503,036 as of December 31, 2025. We used $259,355 in operating activities during the nine months ended September 30, 2026, compared with approximately $123,606 used in operating activities in the comparable prior-year period. Accounts payable increased to $98,145 as of September 30, 2026, from $0 as of December 31, 2025. During the 2026 nine-month period, certain transaction-related expenses totaling approximately $554,499 were paid on our behalf by Goodvision and recorded as noncash capital contributions in the accompanying financial statements.

 

The Company has incurred, and expects to continue to incur, significant public-company and transaction expenses in pursuit of the proposed Business Combination. If our estimates of the costs of identifying, evaluating, negotiating and completing a Business Combination are less than the actual costs, we may have insufficient funds available and may need to obtain additional financing.

 

Our available liquidity, expected expenses and mandatory liquidation date of April 23, 2027 raise substantial doubt about our ability to continue as a going concern, and the disclosed plans do not alleviate that doubt.

 

Related Party Transactions

 

At September 30, 2026, the Sponsors held 2,000,000 Founder Shares and EBC held 175,000 EBC Founder Shares. The Sponsors paid certain formation, operating and deferred offering costs on the Company’s behalf, and no amounts were due to the Sponsors as of September 30, 2026 or December 31, 2025. The Company previously engaged Ascendant, an affiliate of Calisa Holding LP, to provide accounting and SEC reporting support; the agreement was terminated in November 2025, no fees were incurred during the three and nine months ended September 30, 2026 and 2025, and accrued expenses — related party related to Ascendant were $0 and $6,198 as of September 30, 2026 and December 31, 2025, respectively. Calisa Holding LP may charge up to $10,000 per month for office space, utilities and personnel until completion of a Business Combination; the Company incurred $30,000 and $90,000 during the three and nine months ended September 30, 2026, respectively, and no related amounts were payable as of September 30, 2026 or December 31, 2025. On July 31, 2026, Calisa Holding LP entered into a conditional subscription agreement to purchase 250,000 ordinary shares at $10.00 per share for $2,500,000 immediately before the Merger; the subscription had not closed or been funded as of September 30, 2026.

 

Other Contractual Obligations

 

Registration Rights

 

The holders of the Founder Shares, EBC founder shares, Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement dated October 23, 2025 requiring the Company to register such securities for resale. Subject to certain limitations set forth in such agreement, the holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restriction.

 

Underwriting Agreement

 

We granted the underwriters a 45-day option to purchase up to 900,000 additional Units at the IPO price less underwriting discounts and commissions. The underwriters did not exercise the option and delivered an over-allotment termination letter dated October 27, 2025.

 

The underwriters received a cash underwriting discount of $0.20 per Public Unit, totaling $1,200,000, on closing of the IPO.

 

There are no further amounts payable solely in respect of the unexercised over-allotment option.

 

Business Combination Marketing Agreement

 

We engaged EBC as an advisor in connection with our initial Business Combination. Upon consummation, a business combination marketing fee equal to 3.5% of the IPO gross proceeds ($2,100,000) becomes payable, comprising $900,000 in cash and $1,200,000, at the Company’s option, in a convertible note on the terms of the agreement. A further finder fee equal to 1.0% of consideration issued to the target may be payable if the completed Business Combination involves a target introduced by EBC. No fee is due for the business combination marketing services if no Business Combination is consummated.

 

15

 

 

Administration Fee — Related Party

 

Calisa Holding LP may charge an allocable share of overhead of up to $10,000 per month until completion of a Business Combination. The Company incurred $30,000 and $90,000 of such fees during the three and nine months ended September 30, 2026, respectively.

 

Critical Accounting Estimates

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting estimates.

 

Recent Accounting Standards

 

Management evaluates newly issued accounting standards on an ongoing basis to determine their potential impact on the Company’s financial statements.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), requiring public entities to disclose additional information about specified expense categories on an annual and interim basis. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We are evaluating the impact of adoption.

 

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4 – Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

As required by Exchange Act Rules 13a-15 and 15d-15, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based on that evaluation, they concluded that the disclosure controls and procedures were not effective due to a material weakness involving inadequate segregation of duties arising from limited personnel and insufficient written policies and procedures for accounting, information technology, financial reporting and recordkeeping.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

16

 

 

Part II - Other Information

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

On March 21, 2024, Calisa Holding LP, one of our Sponsors, acquired 1,725,000 Founder Shares for $25,000 and subsequently transferred 1,155,750 Founder Shares to Alisa Group Limited, our other Sponsor. In June 2025, we effected a 4-for-3 forward share split, resulting in 2,300,000 Founder Shares, of which 300,000 were subsequently forfeited after termination of the over-allotment option. These issuances were exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

On October 23, 2025, the Company completed its registered IPO of 6,000,000 Public Units, each consisting of one ordinary share, par value $0.000075, and one right to receive one-tenth of one ordinary share upon completion of the initial Business Combination. The Public Units were sold at $10.00 each, for gross proceeds of $60,000,000. EBC acted as sole book-running manager. The securities were registered on Form S-1 (File No. 333-280565), declared effective on October 20, 2025.

 

Simultaneously with the IPO, the Company completed a private placement of 252,500 Private Placement Units at $10.00 each, generating gross proceeds of $2,525,000. The units were purchased by the Sponsors and EBC and are subject to the restrictions described in Note 4. The issuance was exempt under Section 4(a)(2) of the Securities Act.

 

On October 23, 2025, the Company deposited $60,000,000 into the Trust Account maintained by Continental Stock Transfer & Trust Company, as trustee.

 

The IPO transaction costs amounted to $1,960,106, comprising $1,200,000 of cash underwriting discounts and commissions and $760,106 of other offering costs. The accounting treatment is discussed in Note 1.

 

For a description of the proceeds generated in the Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

 

The Company executed conditional subscription agreements dated April 30 and July 31, 2026 contemplating the issuance of an aggregate of 900,000 ordinary shares upon consummation of the proposed Business Combination for aggregate gross proceeds of $9,000,000. As of November 13, 2026, these shares had not been issued.

 

Item 5 – Other Information

 

During the quarter ended September 30, 2026, no director or officer adopted or terminated any (i) “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense conditions of Rule 10b5–1(c) or (ii) “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(c) of Regulation S-K.

 

17

 

 

Item 6 – Exhibits

 

Exhibit No. Description
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document.

 

* Filed herewith

** These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CALISA ACQUISITION CORP
     
Dated: November 13, 2026 By. /s/ Hongfei Zhang
    Hongfei Zhang
    Chief Executive Officer
    (Principal Executive Officer)
     
Dated: November 13, 2026 By. /s/ Jing Lu
    Jing Lu
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

19

 

Keep reading